Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
08/18/1993 | EP0555347A1 SUBSTITUTED INDOLIZINO 1,2-b]QUINOLINONES |
08/18/1993 | EP0555327A1 Alkylidene analogs of 1'-aminospiro-[isoquinoline- 4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones useful as aldose reductase inhibitors in vivo |
08/18/1993 | EP0555309A1 Topical composition with retinoid penetration enhancer |
08/18/1993 | EP0555302A1 Method of treating demyelinating disease |
08/18/1993 | EP0555264A1 Novel compounds |
08/18/1993 | EP0555251A1 Thiazolidine dione derivatives |
08/18/1993 | EP0555249A1 Thiazolidinedione derivatives |
08/18/1993 | EP0555235A1 Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
08/18/1993 | EP0555231A1 REGULATION OF NEOPLASTIC CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR |
08/18/1993 | EP0555210A1 Microbiocidal combinations of materials and their use |
08/18/1993 | EP0516660B1 Use of s-adenosyl methionine as an agent against viral infections by retroviruses |
08/18/1993 | EP0514452B1 Use of insulin sensitizing agents to treat hypertension |
08/18/1993 | EP0493485A4 Erection-inducing methods and compositions |
08/18/1993 | EP0479777B1 Spironolactone composition |
08/18/1993 | EP0368972B1 Method of safely providing anesthesia or conscious sedation |
08/18/1993 | EP0339075B1 Acylated uridine and cytidine and uses thereof |
08/18/1993 | EP0262178B1 Amino acid chelated compositions for delivery to specific biological tissue sites |
08/18/1993 | CN1075320A 4,13-dioxy-bicyclo (8,2,1) tridecylenone derivative, its prepn. method and its intermediate product and said compound-contained medicament |
08/18/1993 | CN1075318A Benzopyran and related LTB4 antagonists |
08/18/1993 | CN1075315A Method for semi-synthesis of taxalkane derivative with metal alkane oxide and beta-lactam |
08/18/1993 | CN1075257A Method for formulating of minocycline hydrochloride capsule |
08/18/1993 | CN1075256A Method for preparation of gynostemma pentaphyllum-dexame asoni abetatis |
08/18/1993 | CN1075255A New medicinal compound for inhibiting gastric acid secretion and with the protection of gastric cell |
08/18/1993 | CN1075254A Compound with cooperation of anti-malaria |
08/18/1993 | CN1075253A Compositions and processes for the sustained release of drugs |
08/18/1993 | CN1021825C Prepn. for aromatic w-alkylimide-tetrahydro-6h-1,3-thiazine-6-one derivatives |
08/18/1993 | CN1021823C Process for substituted benzodihydropyran compound for treating asthma, arthritis and other diseases |
08/18/1993 | CN1021820C Process for n-substituted adenine and n'-substituted cytimidine |
08/18/1993 | CN1021819C Process for diurea derivatives useful as medicaments |
08/18/1993 | CN1021817C Novel polyamine derivatives |
08/18/1993 | CN1021798C Preparation of tinea-curing medicine capable of forming thin film |
08/18/1993 | CA2089533A1 Derivatives of saturated nitrogen heterocycles |
08/18/1993 | CA2089451A1 Herbicidal n-cyanopyridazinones |
08/18/1993 | CA2086989A1 Dosage forms having prolonged active ingredient release |
08/17/1993 | US5237110 19-nor-vitamin d compounds |
08/17/1993 | US5237061 17B-substituted 3-oxo-4-azasteroids, imidazolide intermediate |
08/17/1993 | US5236957 Antiepileptic agents |
08/17/1993 | US5236956 Compounds for the treatment of urinary incontinence |
08/17/1993 | US5236955 Controlling cryptococcus neoformans |
08/17/1993 | US5236953 Alkene, alkyne or cycloalkylene derivatives |
08/17/1993 | US5236952 Catechol derivatives |
08/17/1993 | US5236951 Administering a phenylethanolamine derivative |
08/17/1993 | US5236948 Sulphonamide derivatives |
08/17/1993 | US5236945 1H-indazole-3-acetic acids as aldose reductase inhibitors |
08/17/1993 | US5236943 Administering angiotensin II receptor blockers |
08/17/1993 | US5236942 5-aryl-4-alkyl-3H-1,2,4-triazole-3-thiones useful in the treatment of Altzheimer's dementia |
08/17/1993 | US5236937 Pyridinyl compounds which are useful as angiotensin ii antagonists |
08/17/1993 | US5236936 Pyridine compounds which are useful as angiotensin ii receptor antagonists |
08/17/1993 | US5236933 Use of a combination of angiotensin-converting enzyme inhibitor and calcium antagonist for the treatment of proteinuria |
08/17/1993 | US5236932 Administering potassium channel blocker to brain |
08/17/1993 | US5236927 Reduced toxicity; side effect reduction |
08/17/1993 | US5236921 Administrering for treatment of neutrogenic inflammation of the respiratory trart |
08/17/1993 | US5236920 Free-flowing; foods |
08/17/1993 | US5236918 6-aryl-3-cyanaminopyridazines, their preparation and use and medicaments containing them |
08/17/1993 | US5236917 Respiratory system disorders, antiarthritic agents |
08/17/1993 | US5236914 Derivatives of metalloporphyrins and application thereof for therapeutic purposes and in preparing hybrid molecules |
08/17/1993 | US5236912 Antiandrogenic [3,2-c]pyrazole and [3,2-d]triazole steroids |
08/17/1993 | US5236908 Using adenosine antagonist |
08/17/1993 | US5236907 Ocular hypotensive agents |
08/17/1993 | US5236906 Adrenocortical hormone and hyaluronic acid; skin diseases |
08/17/1993 | US5236904 Erection-inducing methods and compositions |
08/17/1993 | US5236714 Administering abuse substance in permeable form in conjunction with an antagonist in impermeable form; eliminates immediate "high" without diminishing therapeutic value |
08/17/1993 | US5236709 Limulus test-positive plant glycolipid and method of stimulating the immunity system of an animal |
08/17/1993 | US5236708 Reduced-protein subunit vaccine for swine dysentery |
08/17/1993 | US5236705 Fibrinolysis |
08/17/1993 | US5236701 Ingestible hydrophilic polymeric amines useful for lowering blood cholesterol |
08/17/1993 | US5236700 Zirconium aluminum glycinate and-or aluminum chlorohydrate |
08/17/1993 | US5236697 Product for treatment of acne and other skin conditions |
08/17/1993 | US5236609 Gel of acrylic acid polymer, polyhydroxy compound, water |
08/17/1993 | CA1321393C Besylate salt of amlodipine |
08/17/1993 | CA1321391C Substituted pyridine-2,4-dicarboxylic acid derivatives, processes for their preparation, the use thereof and medicaments based on these compounds |
08/17/1993 | CA1321389C Antitumor alkaloids |
08/17/1993 | CA1321387C Therapeutic nucleosides |
08/17/1993 | CA1321363C Application of oligonucleotides linked to an intercalating agent, especially as a drug |
08/17/1993 | CA1321356C Castanospermine for inhibiting tumor metastasis |
08/17/1993 | CA1321355C Method of treating patients suffering from chronic pain or chronic cough |
08/17/1993 | CA1321354C Use of c-5 mono-substituted barbiturates to treat disorders of uric acid metabolism |
08/17/1993 | CA1321353C Diuretic or antihypertensive composition |
08/17/1993 | CA1321352C Pharmaceutical compositions of piroxicam in aqueous solutions and process for their preparation |
08/17/1993 | CA1321350C Method of inhibiting the transmission of aids virus |
08/17/1993 | CA1321349C Therapeutic combination of free-radical scavenger or metabolic inhibitor and biologically active protein |
08/15/1993 | CA2089470A1 Azaindoles, preparation processes and medicinal products containing them |
08/15/1993 | CA2089185A1 Biphenyl-substituted quinoline derivatives |
08/14/1993 | WO1993016024A1 Novel antitumor compound, compositions and method of use |
08/14/1993 | CA2129956A1 Novel antitumor compound, compositions and method of use |
08/14/1993 | CA2089466A1 Benzimidazolyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
08/14/1993 | CA2088455A1 Combination of potassium channel activator and sulfhydryl containing compound and methods of employing such combination |
08/12/1993 | DE4307257A1 Control and prevention of non-putrefactive disease of human and animals esp. AIDS and BSE - using L-tryptophan, indole or deriv., ascorbic acid, methane or hydrogen@ to increase body indole content |
08/12/1993 | DE4244090A1 Deactivating agent for active oxygen - is amino-thiosulphonic acid cpd. useful in treatment of, e.g. lung or cardiovascular disorders, or diabetes |
08/12/1993 | DE4201196A1 Use of multi component compsn. contg. alpha lipoic acid and vitamin(s) |
08/12/1993 | CA2089141A1 Imidazo[1,2-a]pyridines, pharmaceutical compositions containing these compounds and processes for preparing them |
08/11/1993 | EP0555175A1 Biaryl substituted 4-amino-butyric acid amides |
08/11/1993 | EP0555149A1 Use of oxazopyrroloquinolines and pyrroloquinolinequinones for the manufacture of nerve growth factor production accelerators |
08/11/1993 | EP0555068A1 Oxime derivatives as 5-lipoxygenase inhibitors |
08/11/1993 | EP0555067A1 Hydroxylamine derivatives as 5-lipoxygenase inhibitors |
08/11/1993 | EP0555042A1 Pharmaceutical composition for inhibiting platelet aggregation |
08/11/1993 | EP0555036A2 Antitumor compositions and methods of treatment |
08/11/1993 | EP0554898A2 Photocurable glycosaminoglycan derivatives, crosslinked glycosaminoglycans and method of production thereof |
08/11/1993 | EP0554897A2 Novel sterol derivative, process for producing the same and dermatologic external preparation |
08/11/1993 | EP0554861A1 The use of inositoltriphosphate for the treatment of renal diseases |